BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 2, 2005
View Archived Issues
DA-8159 as a treatment for diabetic erectile dysfunction
Read More
CC-4047's mechanism of action remains unclear
Read More
NexBio presents Fludase, a novel antiinfluenza recombinant fusion protein / News in Context
Read More
Two liposomal lurtotecan regimens induce antitumor effects in relapsed ovarian cancer
Read More
CEP-8983 chemosensitizes resistant cells and xenografts
Read More
BTS-2 inhibitory activity depends on redox state of tNOX
Read More
APF-530 enters phase II for CINV in cancer patients
Read More
ISTA seeks green light for phase III trial of combination ophthalmic product
Read More
ZLB Behring to study C1-INH concentrate for hereditary angioedema
Read More
Inspire reports ophthalmic programs update
Read More
Mitsubishi Chemical and Mitsubishi Pharma to form joint holding company
Read More
Phase I cancer study of CYT-997 set to begin in May
Read More
Prism to market Penwest's PW-2101 in U.S., Canada
Read More
Vical's bivalent CMV vaccine set for phase II
Read More
ISIS-369645 enters development for asthma
Read More
New treatments for cancer covered in recent patents
Read More
AS-1410 selected for phase I evaluation against cancer
Read More
Complete tumor regression in mice treated with huC242-DM4
Read More
First, highly selective 5-HT1D antagonist reported
Read More
Novel antihypertensive agents discovered at Bristol-Myers Squibb
Read More
Santarus reports new formulations of omeprazole for treating acid-induced gastrointestinal disorders
Read More
New antidiabetic agents from Ligand and Takeda
Read More
Phase I data confirm MVA-3000 vaccine is safe and immunogenic in healthy volunteers
Read More
Evidence suggests a link between sleep disorders and metabolic syndrome in mice
Read More
UNBS-1450 demonstrates in vitro and in vivo anticancer activity
Read More